Literature DB >> 11820256

Trends in species causing fungaemia in a tertiary care medical centre over 12 years.

P N Malani1, S F Bradley, R S Little, C A Kauffman.   

Abstract

Trends in the species of yeast causing fungaemia over a 12-year period at a large tertiary care medical centre were reviewed. A total of 966 unique episodes of fungaemia occurred in 898 patients. There was an overall trend toward fewer fungaemic episodes due to Candida albicans and more due to Candida glabrata and Candida parapsilosis. However, C. albicans remained the predominant species causing fungaemia, and the proportion due to other species varied from year to year. Candida glabrata was disproportionately isolated from older adults, whereas C. parapsilosis was common among neonates and infants. The trends of increasing isolation of C. glabrata and decreasing isolation of C. albicans were associated with increasing usage of fluconazole, but changes in the proportion of fungaemias due to other species appeared to have no association with fluconazole usage.

Entities:  

Mesh:

Year:  2001        PMID: 11820256     DOI: 10.1046/j.1439-0507.2001.00662.x

Source DB:  PubMed          Journal:  Mycoses        ISSN: 0933-7407            Impact factor:   4.377


  14 in total

1.  Use of denaturing high-performance liquid chromatography for rapid detection and identification of seven Candida species.

Authors:  Oliver Goldenberg; Stefanie Herrmann; Thomas Adam; Gina Marjoram; George Hong; Ulf B Göbel; Barbara Graf
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 3.  Epidemiology, incidence and risk factors for invasive candidiasis in high-risk patients.

Authors:  Ercole Concia; Anna Maria Azzini; Michela Conti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 4.  The role of the laboratory in the diagnosis of invasive candidiasis.

Authors:  Maria Teresa Montagna; Giuseppina Caggiano; Elisa Borghi; Giulia Morace
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 5.  Antifungal prophylaxis in pediatric hematology/oncology: new choices & new data.

Authors:  Christopher C Dvorak; Brian T Fisher; Lillian Sung; William J Steinbach; Michael Nieder; Sarah Alexander; Theoklis E Zaoutis
Journal:  Pediatr Blood Cancer       Date:  2011-11-18       Impact factor: 3.167

6.  Global trends in candidemia: review of reports from 1995-2005.

Authors:  Juliette Morgan
Journal:  Curr Infect Dis Rep       Date:  2005-11       Impact factor: 3.725

Review 7.  Anidulafungin, a new echinocandin: effectiveness and tolerability.

Authors:  Francesco Menichetti
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Gene Expression and Identification Related to Fluconazole Resistance of Candida glabrata Strains.

Authors:  Jae Il Yoo; Chi Won Choi; Kyeong Min Lee; Yeong Seon Lee
Journal:  Osong Public Health Res Perspect       Date:  2010-12-07

9.  Geographic distribution of endemic fungal infections among older persons, United States.

Authors:  John W Baddley; Kevin L Winthrop; Nivedita M Patkar; Elizabeth Delzell; Timothy Beukelman; Fenglong Xie; Lang Chen; Jeffrey R Curtis
Journal:  Emerg Infect Dis       Date:  2011-09       Impact factor: 6.883

10.  Epidemiological trends in nosocomial candidemia in intensive care.

Authors:  Matteo Bassetti; Elda Righi; Alessandro Costa; Roberta Fasce; Maria Pia Molinari; Raffaella Rosso; Franco Bobbio Pallavicini; Claudio Viscoli
Journal:  BMC Infect Dis       Date:  2006-02-10       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.